Assignee
ASTRAZENECA AB
US·1,272 granted patents·1,092 pending applications·17,198 citations·filing 1994–2025
Top patents by PatentIndex Score
2,364 records- 0198US12054465B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Granted Aug 6, 2024·3 cites·21 claims
- 0298US11814359B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Nov 14, 2023·4 cites·21 claims
- 0398US11773069B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Oct 3, 2023·6 cites·23 claims
- 0498US11680049B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 20, 2023·5 cites·14 claims
- 0598US11117874B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2020·Granted Sep 14, 2021·15 cites·60 claims
- 0698US10669245B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2019·Granted Jun 2, 2020·16 cites·16 claims
- 0798US9815805B2Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2016·Granted Nov 14, 2017·22 cites·14 claims
- 0898USD450382SCatheterASTRAZENECA AB·Filed 2000·Granted Nov 13, 2001·140 cites·1 claims
- 0997US11673871B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·20 claims
- 1097US11673872B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·14 claims
- 1197US11667615B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·5 cites·15 claims
- 1297US11655222B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1397US11655221B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·22 claims
- 1497US11655223B2Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·21 claims
- 1597US11655224B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1697US10287258B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2017·Granted May 14, 2019·18 cites·6 claims
- 1797US9522894B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2015·Granted Dec 20, 2016·25 cites·8 claims
- 1897US6919338B2Substituted quinazoline derivatives and their use as inhibitors of aurora-2 kinaseASTRAZENECA AB·Filed 2001·Granted Jul 19, 2005·103 cites·12 claims
- 1996US7524957B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2008·Granted Apr 28, 2009·31 cites·22 claims
- 2096US7500964B2Automatically operable safety shield system for syringesASTRAZENECA AB·Filed 2007·Granted Mar 10, 2009·108 cites·17 claims
- 2196US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 2296USD448076SInhalerASTRAZENECA AB·Filed 1998·Granted Sep 18, 2001·56 cites·1 claims
- 2396US6189739B1Pump dispenser with threshold actuation and restoring springASTRAZENECA AB·Filed 1997·Granted Feb 20, 2001·133 cites·23 claims
- 2495US11912727B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2023·Granted Feb 27, 2024·4 cites·13 claims
- 2595US10273227B2C5-anilinoquinazoline compounds and their use in treating cancerASTRAZENECA AB·Filed 2018·Granted Apr 30, 2019·11 cites·24 claims
- 2695US9248140B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted Feb 2, 2016·31 cites·6 claims
- 2795US7125864B2Benzothiazepine derivatives for the treatment of hyperlipidemiaASTRAZENECA AB·Filed 2002·Granted Oct 24, 2006·86 cites·11 claims
- 2895US6908920B2Pyrimidine derivativesASTRAZENECA AB·Filed 2001·Granted Jun 21, 2005·124 cites·10 claims
- 2995US6875872B1CompoundsASTRAZENECA AB·Filed 2000·Granted Apr 5, 2005·43 cites·12 claims
- 3095US6838089B1Antigen delivery system and method of productionASTRAZENECA AB·Filed 1999·Granted Jan 4, 2005·196 cites·65 claims
- 3195US6838464B22,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agentsASTRAZENECA AB·Filed 2001·Granted Jan 4, 2005·183 cites·14 claims
- 3295US6593326B12,4-diamino pyrimidine compounds having anti-cell proliferative activityASTRAZENECA AB·Filed 1999·Granted Jul 15, 2003·317 cites·13 claims
- 3394US12195485B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2022·Granted Jan 14, 2025·4 cites·23 claims
- 3494US11813246B2Pharmaceutical compositionASTRAZENECA AB·Filed 2021·Granted Nov 14, 2023·7 cites·8 claims
- 3594US11325906B2Chemical compoundsASTRAZENECA AB·Filed 2020·Granted May 10, 2022·8 cites·2 claims
- 3694US7875715B2Compounds for the treatment of multi-drug resistant bacterial infectionsASTRAZENECA AB·Filed 2006·Granted Jan 25, 2011·13 cites·1 claims
- 3794US7745475B2Heteroaryl benzamide derivatives as GLK activatorsASTRAZENECA AB·Filed 2005·Granted Jun 29, 2010·14 cites·3 claims
- 3894US7696214B2Quinazoline derivatives for the treatment of tumoursASTRAZENECA AB·Filed 2005·Granted Apr 13, 2010·11 cites·5 claims
- 3994US7118552B2Automatically operable safety shield system for syringesASTRAZENECA AB·Filed 2001·Granted Oct 10, 2006·195 cites·20 claims
- 4094US6774122B2FormulationASTRAZENECA AB·Filed 2001·Granted Aug 10, 2004·68 cites·9 claims
- 4194USD455953SBlister packASTRAZENECA AB·Filed 2001·Granted Apr 23, 2002·44 cites·1 claims
- 4294USD455344SBlister packASTRAZENECA AB·Filed 2001·Granted Apr 9, 2002·47 cites·1 claims
- 4394US2026055067A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 4493US7642259B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted Jan 5, 2010·18 cites·3 claims
- 4593US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 4693US7485722B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2007·Granted Feb 3, 2009·29 cites·13 claims
- 4793US7250419B2Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2005·Granted Jul 31, 2007·16 cites·14 claims
- 4893US7238684B2Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing themASTRAZENECA AB·Filed 2003·Granted Jul 3, 2007·93 cites·12 claims
- 4993US7226943B2Benzothiepine ileal bile acid transport inhibitorsASTRAZENECA AB·Filed 2002·Granted Jun 5, 2007·80 cites·21 claims
- 5093US7199140B2Vinyl phenyl derivatives as GLK activatorsASTRAZENECA AB·Filed 2002·Granted Apr 3, 2007·52 cites·5 claims
Showing the top 50 of 2,364 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ASTRAZENECA AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →